Publications by authors named "Jayanthi Wolf"

Claim this Profile
C
Characterization of integration frequency and insertion sites of adenovirus DNA into mouse liver genomic DNA following intravenous injection.
Zhibin Wang, Philip J Troilo, Thomas G Griffiths, Laural B Harper, Amy B Barnum, Jayanthi Wolf

Gene Ther· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of Pandemic Vaccines: ERVEBO Case Study.
Jayanthi Wolf, Risat Jannat, Sheri Dubey, Sean Troth, Matthew T Onorato

Vaccines (Basel)· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Environmental Risk Assessment for rVSVΔG-ZEBOV-GP, a Genetically Modified Live Vaccine for Ebola Virus Disease.
Joan G Tell, Beth-Ann G Coller, Sheri A Dubey, Ursula Jenal, William Lapps, Jayanthi Wolf

Vaccines (Basel)· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Review of Current Vaccine Development Strategies to Prevent Coronavirus Disease 2019 (COVID-19).
Bindu M Bennet, Jayanthi Wolf, Rodrigo Laureano, Rani S Sellers

Toxicol Pathol· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of export regulations on recombinant viral vaccine development for emerging infectious diseases.
Jayanthi Wolf, Ryan Hansen, Kimberly Hassis, William Lapps, Emese Warmuth

Vaccine· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Applying lessons from the Ebola vaccine experience for SARS-CoV-2 and other epidemic pathogens.
Jayanthi Wolf, Samantha Bruno, Michael Eichberg, Risat Jannat, Sharon Rudo

NPJ Vaccines· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Scientific and Regulatory Policy Committee Points to Consider*: Approaches to the Conduct and Interpretation of Vaccine Safety Studies for Clinical and Anatomic Pathologists.
Rani S Sellers, Keith Nelson, Bindu Bennet, Jayanthi Wolf, Niraj Tripathi

Toxicol Pathol· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nonclinical safety of tildrakizumab, a humanized anti-IL-23p19 monoclonal antibody, in nonhuman primates.
Michael Santostefano, Danuta Herzyk, Diana Montgomery, Jayanthi Wolf

Regul Toxicol Pharmacol· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
rVSVΔG-ZEBOV-GP (also designated V920) recombinant vesicular stomatitis virus pseudotyped with Ebola Zaire Glycoprotein: Standardized template with key considerations for a risk/benefit assessment.
Thomas P Monath, Patricia E Fast, Kayvon Modjarrad, David K Clarke, Brian K Martin, Jayanthi Wolf

Vaccine X· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current strategies in the non-clinical safety assessment of biologics: New targets, new molecules, new challenges.
Frank R Brennan, Laura Andrews, Antonio R Arulanandam, Jorg Blumel, Jim Fikes, Jayanthi Wolf

Regul Toxicol Pharmacol· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of a 9-valent HPV vaccine in Sprague-Dawley rats: Nonclinical studies assessing general, reproductive, and developmental toxicity.
L David Wise, Jayanthi J Wolf, Lisa M Plitnick

Vaccine· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical development of a recombinant Ebola vaccine in the midst of an unprecedented epidemic.
Beth-Ann G Coller, Jeffrey Blue, Rituparna Das, Sheri Dubey, Lynn Finelli, Jayanthi Wolf

Vaccine· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Tetravalent Sub-unit Dengue Vaccine Formulated with Ionizable Cationic Lipid Nanoparticle induces Significant Immune Responses in Rodents and Non-Human Primates.
Gokul Swaminathan, Elizabeth A Thoryk, Kara S Cox, Jeffrey S Smith, Jayanthi J Wolf

Sci Rep· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reliable quantification of mRNA in archived formalin-fixed tissue with or without paraffin embedding.
Zhibin Wang, Jose A Lebron, Jayanthi J Wolf

J Pharmacol Toxicol Methods· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An Evaluation of the Impact of PD-1 Pathway Blockade on Reproductive Safety of Therapeutic PD-1 Inhibitors.
Frederique M Poulet, Jayanthi J Wolf, Danuta J Herzyk, Joseph J DeGeorge

Birth Defects Res B Dev Reprod Toxicol· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multi-species assay for siRNA-mediated mRNA knockdown analysis without the need for RNA purification.
Zhibin Wang, Stephen J Pacchione, Zhutian Niu, Philip J Troilo, Thomas G Griffiths, Jayanthi J Wolf

J Pharmacol Toxicol Methods· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lack of effects on male fertility from a quadrivalent HPV vaccine in Sprague-Dawley rats.
L David Wise, Cindy J Pauley, Bindhu Michael, Jayanthi J Wolf

Birth Defects Res B Dev Reprod Toxicol· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nonclinical safety assessment of vaccines and adjuvants.
Jayanthi J Wolf, Catherine V Kaplanski, Jose A Lebron

Methods Mol Biol· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lack of effects on fertility and developmental toxicity of a quadrivalent HPV vaccine in Sprague-Dawley rats.
L David Wise, Jayanthi J Wolf, Catherine V Kaplanski, Cindy J Pauley, Brian J Ledwith

Birth Defects Res B Dev Reprod Toxicol· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantifying the titer and quality of adenovirus stocks.
Fubao Wang, Bill C Mathis, Allison Montalvo, Jayanthi J Wolf, John A Lewis

Methods Mol Biol· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Application of PCR technology in vaccine product development.
Jayanthi J Wolf, Liman Wang, Fubao Wang

Expert Rev Vaccines· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Production and formulation of adenovirus vectors.
Nedim E Altaras, John G Aunins, Robert K Evans, Amine Kamen, John O Konz, Jayanthi J Wolf

Adv Biochem Eng Biotechnol· June 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Ensuring the quality, potency and safety of vaccines during preclinical development.
Jose A Lebron, Jayanthi J Wolf, Catherine V Kaplanski, Brian J Ledwith

Expert Rev Vaccines· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Using QPCR to assign infectious potencies to adenovirus based vaccines and vectors for gene therapy: toward a universal method for the facile quantitation of virus and vector potency.
Fubao Wang, Alan C Puddy, Bill C Mathis, Allison G Montalvo, Anthonise A Louis, Jayanthi J Wolf

Vaccine· August 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis